Therapeutic Antibodies for Infectious Diseases: Recent Past, Present, and Future.

This research paper explores the recent history, current state, and future potential of therapeutic antibodies for infectious diseases. The methodology focuses on highlighting the use of antibodies to treat COVID-19 over the past five years, as well as the challenges in rapidly developing these therapies in response to pandemic threats. The key finding is that emerging technologies, such as AI-driven design, may offer exciting opportunities for the development of a broad class of protein therapies to combat infectious diseases. The significance of this research lies in its potential to inform the development of more effective and responsive interventions for future pandemic situations. The main limitation is the narrow focus on the COVID-19 example, which may not fully capture the broader landscape of therapeutic antibody use for infectious diseases.